High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.-论文-万方医学网

第一作者： Marcel,Wiesweg

第一单位： Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

作者： Marcel,Wiesweg ^[1] ; Wilfried E E,Eberhardt ^[2] ; Henning,Reis ^[3] ; Saskia,Ting ^[3] ; Nikoleta,Savvidou ^[1] ; Charlotte,Skiba ^[1] ; Thomas,Herold ^[4] ; Daniel C,Christoph ^[1] ; Johannes,Meiler ^[1] ; Karl,Worm ^[3] ; Stefan,Kasper ^[1] ; Dirk,Theegarten ^[3] ; Jörg,Hense ^[1] ; Thomas,Hager ^[3] ; Kaid,Darwiche ^[5] ; Filiz,Oezkan ^[5] ; Clemens,Aigner ^[6] ; Stefan,Welter ^[6] ; Hilmar,Kühl ^[7] ; Martin,Stuschke ^[8] ; Kurt W,Schmid ^[4] ; Martin,Schuler ^[9]

作者单位： Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. ^[1] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Thoracic Oncology, West German Lung Center, Ruhrlandklinik, University Hospital Essen, Essen, Germany. ^[2] Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. ^[3] Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. ^[4] Division of Interventional Pneumology, West German Lung Center, Ruhrlandklinik, University Hospital Essen, Essen, Germany. ^[5] Division of Thoracic Surgery, West German Lung Center, Ruhrlandklinik, University Hospital Essen, Essen, Germany. ^[6] Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. ^[7] German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. ^[8] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Thoracic Oncology, West German Lung Center, Ruhrlandklinik, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. Electronic address: martin.schuler@uk-essen.de. ^[9]

主题词腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);综合疗法(Combined Modality Therapy);女(雌)性(Female);随访研究(Follow-Up Studies);基因重排(Gene Rearrangement);人类(Humans);原位杂交, 荧光(In Situ Hybridization, Fluorescence);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤分期(Neoplasm Staging);癌基因(Oncogenes);患病率(Prevalence);预后(Prognosis);前瞻性研究(Prospective Studies);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);原癌基因蛋白质类(Proto-Oncogene Proteins);存活率(Survival Rate)

DOI 10.1016/j.jtho.2016.08.137

PMID 27575422

发布时间 2022-03-10

检索历史清除

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.

Journal of thoracic oncology

相似文献

Journal of thoracic oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.

Journal of thoracic oncology

相似文献

Journal of thoracic oncology

相关期刊

检索历史清除